pharmaceutical-technology.com
61%
901
Eli Lilly signs Covid-19 drug development deal with Junshi Biosciences
Eli Lilly has signed an agreement with China-based biopharmaceutical firm Junshi Biosciences to jointly develop therapeutic antibodies to prevent and treat Covid-19.